Patents by Inventor Juan Jose Diaz Gil

Juan Jose Diaz Gil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of liver growth factor (LGF) as a neural tissue regenerator
    Patent number: 9144597
    Abstract: A method of treating neurodegenerative diseases, such as Alzheimer's disease, with LGF administered systemically.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: September 29, 2015
    Inventor: Juan Jose Diaz Gil
  • USE OF LIVER GROWTH FACTOR (LGF) AS A NEURAL TISSUE REGENERATOR
    Publication number: 20140113859
    Abstract: A method of treating neurodegenerative diseases, such as Alzheimer's disease, with LGF administered systemically.
    Type: Application
    Filed: December 24, 2013
    Publication date: April 24, 2014
    Inventor: Juan Jose DIAZ GIL
  • Use of liver growth factor (LGF) as a neural tissue regenerator
    Patent number: 8642551
    Abstract: The invention comprises the use of LGF in the production of medicinal products that can be used in the pleiotropic tissue regeneration of one or more damaged tissues, in which at least one of the damaged tissues forms part of the central nervous system and the medicinal product is intended to be administered systemically. The invention is based on the fact that intraperitoneal administration of LGF can promote a positive effect on a Parkinson's disease model. As such, in a preferred embodiment of the invention, the medicinal product is intended for the treatment of Parkinson's disease, particularly when the medicinal product is intended for humans.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: February 4, 2014
    Inventor: Juan Jose Diaz Gil
  • USE OF LIVER GROWTH FACTOR (LGF) AS A NEURAL TISSUE REGENERATOR
    Publication number: 20110034382
    Abstract: The invention comprises the use of LGF in the production of medicinal products that can be used in the pleiotropic tissue regeneration of one or more damaged tissues, in which at least one of the damaged tissues forms part of the central nervous system and the medicinal product is intended to be administered systemically. The invention is based on the fact that intraperitoneal administration of LGF can promote a positive effect on a Parkinson's disease model. As such, in a preferred embodiment of the invention, the medicinal product is intended for the treatment of Parkinson's disease, particularly when the medicinal product is intended for humans.
    Type: Application
    Filed: April 17, 2009
    Publication date: February 10, 2011
    Applicant: Fun Par La Inves Bio Del Hos Uni Puerta De Hierro
    Inventor: Juan Jose Diaz Gil